Jacobi Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.56M Sell
23,133
-13
-0.1% -$1.44K 0.17% 121
2025
Q1
$2.59M Sell
23,146
-3,924
-14% -$440K 0.19% 110
2024
Q4
$2.5M Sell
27,070
-42
-0.2% -$3.88K 0.19% 109
2024
Q3
$2.27M Buy
27,112
+8,246
+44% +$691K 0.17% 122
2024
Q2
$1.29M Buy
18,866
+1,802
+11% +$124K 0.11% 173
2024
Q1
$1.25M Buy
17,064
+3
+0% +$220 0.12% 169
2023
Q4
$1.38M Buy
17,061
+98
+0.6% +$7.94K 0.14% 137
2023
Q3
$1.27M Sell
16,963
-899
-5% -$67.4K 0.14% 137
2023
Q2
$1.38M Sell
17,862
-1,601
-8% -$123K 0.15% 131
2023
Q1
$1.61M Sell
19,463
-250
-1% -$20.7K 0.19% 107
2022
Q4
$1.69M Sell
19,713
-681
-3% -$58.5K 0.21% 97
2022
Q3
$1.26M Buy
20,394
+289
+1% +$17.8K 0.17% 123
2022
Q2
$1.24M Buy
20,105
+1,439
+8% +$88.9K 0.17% 126
2022
Q1
$1.11M Buy
18,666
+2,321
+14% +$138K 0.13% 153
2021
Q4
$1.19M Buy
16,345
+1,173
+8% +$85.2K 0.14% 141
2021
Q3
$1.06M Sell
15,172
-270
-2% -$18.9K 0.13% 136
2021
Q2
$1.06M Sell
15,442
-75
-0.5% -$5.16K 0.14% 129
2021
Q1
$1M Buy
15,517
+112
+0.7% +$7.24K 0.15% 130
2020
Q4
$972K Buy
15,405
+2,145
+16% +$135K 0.15% 122
2020
Q3
$818K Buy
13,260
+1,189
+10% +$73.3K 0.14% 124
2020
Q2
$924K Buy
12,071
+123
+1% +$9.42K 0.17% 104
2020
Q1
$937K Sell
11,948
-96
-0.8% -$7.53K 0.2% 92
2019
Q4
$769K Buy
12,044
+297
+3% +$19K 0.14% 137
2019
Q3
$763K Buy
11,747
+369
+3% +$24K 0.15% 127
2019
Q2
$768K Buy
11,378
+9,530
+516% +$643K 0.16% 124
2019
Q1
$120K Sell
1,848
-449
-20% -$29.2K 0.03% 292
2018
Q4
$144K Sell
2,297
-719
-24% -$45.1K 0.04% 260
2018
Q3
$233K Buy
3,016
+418
+16% +$32.3K 0.06% 199
2018
Q2
$184K Buy
2,598
+583
+29% +$41.3K 0.05% 219
2018
Q1
$147K Buy
2,015
+434
+27% +$31.7K 0.04% 236
2017
Q4
$118K Buy
1,581
+943
+148% +$70.4K 0.04% 235
2017
Q3
$52K Buy
638
+68
+12% +$5.54K 0.02% 335
2017
Q2
$40K Buy
570
+117
+26% +$8.21K 0.02% 340
2017
Q1
$30K Buy
453
+2
+0.4% +$132 0.02% 302
2016
Q4
$33K Sell
451
-125
-22% -$9.15K 0.02% 266
2016
Q3
$45K Buy
576
+2
+0.3% +$156 0.02% 249
2016
Q2
$49K Buy
+574
New +$49K 0.02% 223